# Spinal Cavernous Malformations: A Narrative Review

**Authors:** Aleeza Safdar, Ali Osman, Rouzbeh Motiei-Langroudi

PMC · DOI: 10.3390/neurosci7010017 · NeuroSci · 2026-02-02

## TL;DR

This paper reviews treatment options for spinal cavernous malformations, focusing on when surgery or conservative care is best based on patient and lesion factors.

## Contribution

The paper provides a narrative review of SCCM management strategies, emphasizing decision-making factors and outcomes of surgical versus conservative approaches.

## Key findings

- Surgery is recommended for symptomatic patients with large lesions to prevent hemorrhage and improve outcomes.
- Conservative management is suitable for small, asymptomatic lesions with regular monitoring.
- Early surgery within 3 months is associated with better long-term outcomes compared to delayed intervention.

## Abstract

The management of spinal cord cavernous malformations (SCCMs) involves critical decisions between surgical and conservative treatments, informed by the patient’s preoperative neurological status, lesion characteristics, and timing of intervention (early or delayed surgery). Surgery remains an option for symptomatic patients, especially those with significant or progressive neurological deficits and large lesions, aiming for gross total excision to prevent (re)hemorrhage and improve outcomes. Conversely, conservative management is appropriate for small, asymptomatic lesions, with regular monitoring to detect changes necessitating surgery. Studies highlight the benefits and risks of both approaches. Surgical resection typically leads to neurological recovery, although worse preoperative status and larger lesions predict poorer outcomes. Other factors influencing surgical success include lesion location and timing of surgery, with early surgery (within 3 months) generally yielding better long-term outcomes. Future research should focus on the optimal timing of surgery, particularly the benefits of urgent intervention.

## Full-text entities

- **Genes:** KRIT1 (KRIT1 ankyrin repeat containing) [NCBI Gene 889] {aka CAM, CCM1}, CCM2 (CCM2 scaffold protein) [NCBI Gene 83605] {aka C7orf22, OSM, PP10187}, PDCD10 (programmed cell death 10) [NCBI Gene 11235] {aka CCM3, TFAR15}, MMS [NCBI Gene 338340]
- **Diseases:** venous malformation (MESH:C563977), urinary or bowel dysfunction (MESH:D015212), CSF leakage (MESH:D019585), Bleeding (MESH:D006470), gait ataxia (MESH:D020234), SCCM lesions (MESH:D009059), dysesthesia (MESH:D010292), vascular malformations (MESH:D054079), kyphosis (MESH:D007738), tethering (MESH:D009436), stenosis (MESH:D003251), neurologic deficit (MESH:D009461), spinal cavernomas (MESH:D013122), SCCMs (MESH:D013118), paraplegia (MESH:D010264), respiratory distress (MESH:D012128), quadriplegia (MESH:D011782), neurological impairment (MESH:D009422), unstable (MESH:D000789), cervical lesions (MESH:D002575), injury to (MESH:D014947), gliosis (MESH:D005911), dysesthetic pain (MESH:D010146), intracerebral hemorrhage (MESH:D002543), infection (MESH:D007239), calcification (MESH:D002114), Motor weakness (MESH:D018908), intramedullary vascular lesions (MESH:D014652), sensory disturbance (MESH:D012678), venous thrombosis (MESH:D020246), radiculopathy (MESH:D011843), intracranial lesion (MESH:D020765), cavernous malformation (MESH:D020786)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921962/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12921962/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921962/full.md

---
Source: https://tomesphere.com/paper/PMC12921962